Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (vol 21, pg 3497, 2013)

被引：0
|
作者：
von Moos, Roger [1 ]
Body, Jean-Jacques [2 ]
Egerdie, Blair [3 ]
Stopeck, Alison [4 ]
Brown, Janet E. [5 ,6 ]
Damyanov, Danail [7 ]
Fallowfield, Lesley J. [8 ]
Marx, Gavin [9 ]
Cleeland, Charles S. [10 ]
Patrick, Donald L. [11 ]
Palazzo, Felipe G. [12 ]
Qian, Yi [13 ]
Braun, Ada [13 ]
Chung, Karen [13 ]
机构：
[1] Kantonsspital Graubunden, CH-7000 Chur, Switzerland
[2] Univ Libre Brussels, Chu Brugmann, Brussels, Belgium
[3] Urol Associates Urol Med Res, Kitchener, ON, Canada
[4] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[5] Canc Res UK Expt Canc Med Ctr, Leeds, W Yorkshire, England
[6] Canc Res UK Expt Canc Med Ctr, Sheffield, S Yorkshire, England
[7] Natl Hosp Treatment Oncol, Sofia, Bulgaria
[8] Univ Sussex, SHORE C, Brighton, E Sussex, England
[9] Univ Sydney, Sydney Adventist Hosp, Sydney, NSW 2006, Australia
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[11] Univ Washington, Seattle, WA 98195 USA
[12] CAIPO, San Miguel De Tucuman, Argentina
[13] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
SUPPORTIVE CARE IN CANCER | 2014年 / 22卷 / 08期
关键词：
D O I：
10.1007/s00520-014-2293-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2309 / 2310
页数：2
相关论文
共 50 条
  • [1] Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
    Roger von Moos
    Jean-Jacques Body
    Blair Egerdie
    Alison Stopeck
    Janet E. Brown
    Danail Damyanov
    Lesley J. Fallowfield
    Gavin Marx
    Charles S. Cleeland
    Donald L. Patrick
    Felipe G. Palazzo
    Yi Qian
    Ada Braun
    Karen Chung
    Supportive Care in Cancer, 2013, 21 : 3497 - 3507
  • [2] Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
    von Moos, Roger
    Body, Jean-Jacques
    Egerdie, Blair
    Stopeck, Alison
    Brown, Janet E.
    Damyanov, Danail
    Fallowfield, Lesley J.
    Marx, Gavin
    Cleeland, Charles S.
    Patrick, Donald L.
    Palazzo, Felipe G.
    Qian, Yi
    Braun, Ada
    Chung, Karen
    SUPPORTIVE CARE IN CANCER, 2013, 21 (12) : 3497 - 3507
  • [3] Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
    Roger von Moos
    Jean-Jacques Body
    Blair Egerdie
    Alison Stopeck
    Janet E. Brown
    Danail Damyanov
    Lesley J. Fallowfield
    Gavin Marx
    Charles S. Cleeland
    Donald L. Patrick
    Felipe G. Palazzo
    Yi Qian
    Ada Braun
    Karen Chung
    Supportive Care in Cancer, 2014, 22 : 2309 - 2310
  • [4] Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid
    Cleeland, Charles S.
    Body, Jean-Jacques
    Stopeck, Alison
    von Moos, Roger
    Fallowfield, Lesley
    Mathias, Susan D.
    Patrick, Donald L.
    Clemons, Mark
    Tonkin, Katia
    Masuda, Norikazu
    Lipton, Allan
    de Boer, Richard
    Salvagni, Stefania
    Oliveira, Celia Tosello
    Qian, Yi
    Jiang, Qi
    Dansey, Roger
    Braun, Ada
    Chung, Karen
    CANCER, 2013, 119 (04) : 832 - 838
  • [5] Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
    Stopeck, Alison T.
    Lipton, Allan
    Body, Jean-Jacques
    Steger, Guenther G.
    Tonkin, Katia
    de Boer, Richard H.
    Lichinitser, Mikhail
    Fujiwara, Yasuhiro
    Yardley, Denise A.
    Viniegra, Maria
    Fan, Michelle
    Jiang, Qi
    Dansey, Roger
    Jun, Susie
    Braun, Ada
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : 5132 - 5139
  • [6] A meta-analysis of results from two randomized, double-blind studies of denosumab versus zoledronic acid (ZA) for treatment of bone metastases
    Lipton, A.
    Stopeck, A.
    von Moos, R.
    Henry, D. H.
    Richardson, G. E.
    Rodriguez, G. I.
    Bourgeois, H. P.
    Ke, C.
    Jun, S.
    Dansey, R. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trials
    Lipton, A.
    Stopeck, A.
    von Moos, R.
    Henry, D.
    Richardson, G.
    Rodriguez, G.
    Bourgeois, H.
    Ke, C.
    Jun, S.
    Dansey, R.
    BONE, 2011, 48 (01) : S21 - S21
  • [8] Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma
    von Moos, Roger
    Henry, David
    Vadhan-Raj, Saroj
    Hungria, Vania
    Spencer, Andrew
    Hirsh, Vera
    Wang, Jianming
    Susie, Jun
    Howard, Yeh
    Dansey, Roger
    BONE, 2010, 46 : S44 - S44
  • [9] EVALUATING PAIN AND ANALGESIC USE IN PATIENTS WITH SOLID TUMOURS AND BONE METASTASES RECEIVING DENOSUMAB OR ZOLEDRONIC ACID (ZA) FROM 3 IDENTICALLY-DESIGNED, RANDOMISED, DOUBLE-BLIND, TRIALS
    Woodhead, Sally
    Mayer, Gisela
    Fitzpatrick, Gail
    Frey, Georgette
    Wigginton, Hannah
    Cleeland, Charles
    Braun, Ada
    Qian, Yi
    Chung, Karen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 357 - 357
  • [10] DENOSUMAB VERSUS ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES SECONDARY TO SOLID TUMOURS: AN INTEGRATED ANALYSIS OF THREE PHASE 3 STUDIES
    Stopeck, A. T.
    Richardson, G.
    Siena, S.
    Lipton, A.
    Brown, J.
    Fizazi, K.
    Henry, D.
    Saad, F.
    Ke, C.
    Braun, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S8 - S8
12345